A clinical research group at Yale Medical School anticipates beginning a clinical trial in the near future with pheo/para patients to test a drug already approved for use in multiple types of cancer for efficacy in our patient population.
If you are interested in learning more about this trial and being pre-screened for potential inclusion in this study, please contact Dr. Ranjit Bindra at: ranjit.bindra@yale.edu